Kestra Private Wealth Services’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $846K | Sell |
1,611
-447
| -22% | -$235K | 0.01% | 802 |
|
|
2025
Q1 | $1.31M | Buy |
2,058
+132
| +7% | +$83.7K | 0.02% | 586 |
|
|
2024
Q4 | $1.37M | Buy |
1,926
+220
| +13% | +$157K | 0.02% | 539 |
|
|
2024
Q3 | $1.79M | Buy |
1,706
+331
| +24% | +$348K | 0.03% | 452 |
|
|
2024
Q2 | $1.44M | Sell |
1,375
-377
| -22% | -$396K | 0.03% | 475 |
|
|
2024
Q1 | $1.69M | Sell |
1,752
-20
| -1% | -$19.2K | 0.04% | 419 |
|
|
2023
Q4 | $1.56M | Buy |
1,772
+292
| +20% | +$256K | 0.04% | 420 |
|
|
2023
Q3 | $1.22M | Buy |
1,480
+102
| +7% | +$83.9K | 0.04% | 408 |
|
|
2023
Q2 | $990K | Buy |
1,378
+119
| +9% | +$85.5K | 0.03% | 442 |
|
|
2023
Q1 | $1.03M | Buy |
1,259
+349
| +38% | +$287K | 0.04% | 399 |
|
|
2022
Q4 | $657K | Buy |
910
+421
| +86% | +$304K | 0.03% | 457 |
|
|
2022
Q3 | $337K | Sell |
489
-216
| -31% | -$149K | 0.02% | 611 |
|
|
2022
Q2 | $417K | Sell |
705
-188
| -21% | -$111K | 0.02% | 556 |
|
|
2022
Q1 | $624K | Sell |
893
-193
| -18% | -$135K | 0.03% | 504 |
|
|
2021
Q4 | $686K | Buy |
1,086
+456
| +72% | +$288K | 0.03% | 493 |
|
|
2021
Q3 | $381K | Buy |
630
+16
| +3% | +$9.68K | 0.02% | 619 |
|
|
2021
Q2 | $343K | Sell |
614
-50
| -8% | -$27.9K | 0.02% | 623 |
|
|
2021
Q1 | $314K | Buy |
+664
| New | +$314K | 0.02% | 591 |
|